Author

R. Weigel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Animal Behavior & Cognition· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cancer & tumor microenvironment· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

C. Lyu· 2 shared S. Chen· 2 shared A. K. Bhimani· 1 shared A. Koelpin· 1 shared B. Cassens· 1 shared E. Cho· 1 shared F. Dressler· 1 shared F. Mayer· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Lyu

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The distinct roles of MSH2 and MLH1 in basal-like breast cancer and immune modulation

T. I. Tithi, J. Mo, N. Borcherding, S. Jo, E. Cho, K. E. Cash, M. Honda, L. Wang, K. K. Ahmed, K. Shirlekar, L. Chen, R. Weigel, H. Kates, K. Gibson-Corley, M. Spies, , W. Zhang

This study identifies distinct roles of MSH2 and MLH1 in basal-like breast cancer, showing MSH2 promotes metastasis while MLH1 enhances it, and reveals MSH2's role in immune modulation through IFNAR1 regulation.

bioRxiv · Jul 20, 2023 · PreprintCancer Biology

Active Gαi/o mutants accelerate breast tumor metastasis via the c-Src pathway

C. Lyu, A. K. Bhimani, W. T. Draus, R. Weigel, S. Chen

This study shows that active Gαi/o mutants enhance breast cancer metastasis via the c-Src pathway without affecting primary tumor growth.

bioRxiv · Jan 16, 2023 · PreprintCancer Biology

Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy

C. Lyu, Y. Ye, M. Lensing, K.-U. Wagner, R. Weigel, S. Chen

This study shows that blocking Gi/o-GPCR signaling inhibits HER2-driven breast cancer growth and improves HER2-targeted therapy effectiveness.

bioRxiv · Jun 15, 2021Cancer Biology

Thinking small: next-generation sensor networks close the size gap in vertebrate biologging

S. P. Ripperger, G. G. Carter, R. A. Page, N. Duda, A. Koelpin, R. Weigel, M. Hartmann, T. Nowak, J. Thielecke, M. Schadhauser, J. Robert, S. Herbst, K. Meyer-Wegener, P. Waegemann, W. Schroeder-Preikschat, , F. Mayer

This paper develops a wireless biologging network for tracking small vertebrates with high resolution and low tag weight, demonstrating its application in studying wild bats.

bioRxiv · Sep 18, 2019Animal Behavior & Cognition